The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer
2018 · Oncogene · 94 citations
https://doi.org/10.1038/s41388-018-0553-0
B
Beiqin Yu
Ruijin Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
3.3K
Citations
31
h-index
50
i10-index
Beiqin Yu is an academic researcher from Ruijin Hospital. The author has contributed to research in topics: Cancer-related molecular mechanisms research & MicroRNA in disease regulation & RNA modifications and cancer. The author has an h-index of 31, co-authored 69 publications.
ORCID: 0000-0003-1043-0445Papers by this author
worksTumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV
2014 · Molecular Cancer · 90 citations
https://doi.org/10.1186/1476-4598-13-127
Stromal fibroblasts in the microenvironment of gastric carcinomas promote tumor metastasis via upregulating TAGLN expression
2013 · BMC Cell Biology · 59 citations
https://doi.org/10.1186/1471-2121-14-17
The role of GLI1 for 5-Fu resistance in colorectal cancer
2017 · Cell & Bioscience · 49 citations
https://doi.org/10.1186/s13578-017-0145-7
MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells
2014 · BMC Cancer · 47 citations
https://doi.org/10.1186/1471-2407-14-34
Tumor suppressor lnc-CTSLP4 inhibits EMT and metastasis of gastric cancer by attenuating HNRNPAB-dependent Snail transcription
2021 · Molecular Therapy — Nucleic Acids · 39 citations
https://doi.org/10.1016/j.omtn.2021.02.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat